We are live on
!
Find out more
SIG
Sargent Investment Group Portfolio holdings
AUM
$759M
1-Year Est. Return
28.58%
This Fund
S&P 500
This Quarter
Est. Return
+1.67%
1 Year Est. Return
+28.58%
3 Year Est. Return
+104.74%
5 Year Est. Return
+107.13%
10 Year Est. Return
–
AUM
$797M
AUM Growth
+$95.5M
(+14%)
Cap. Flow
+$94.4M
Cap. Flow
% of AUM
11.84%
Top 10 Holdings %
Top 10 Hldgs %
41%
Holding
264
New
143
Increased
46
Reduced
61
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$9.69M |
| 2 |
AKRE
Akre Focus ETF
AKRE
|
+$6.01M |
| 3 |
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
|
+$3.44M |
| 4 |
FirstService
FSV
|
+$2.49M |
| 5 |
Visa
V
|
+$1.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$10.1M |
| 2 |
CTLP
Cantaloupe
CTLP
|
+$1.12M |
| 3 |
Blackstone
BX
|
+$1.03M |
| 4 |
Apple
AAPL
|
+$952K |
| 5 |
First Trust Capital Strength ETF
FTCS
|
+$809K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.41% |
| 2 | Financials | 11.92% |
| 3 | Healthcare | 7.59% |
| 4 | Consumer Discretionary | 4.99% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THW
251
abrdn World Healthcare Fund
THW
$551M
| $128K | 0.02% |
10,000
| – | – |
|
252
Cemex
CX
$16.3B
| $126K | 0.02% |
11,000
| – | – |
|
|
NAGE
253
Niagen Bioscience
NAGE
$247M
| $95.4K | 0.01% |
15,000
-20,002
| -57% | -$139K |
|
254
Transocean
RIG
$5.82B
| $92.9K | 0.01% |
22,500
| – | – |
|
255
Wendy's
WEN
$1.46B
| $85.8K | 0.01% |
+10,295
| New | +$88.8K |
|
256
Ardelyx
ARDX
$997M
| $81.6K | 0.01% |
+14,000
| New | +$78K |
|
257
Lucid Diagnostics
LUCD
$184M
| $58.9K | 0.01% |
54,030
| – | – |
|
258
Newell Brands
NWL
$2.56B
| $42.2K | 0.01% |
+11,350
| New | +$45.9K |
|
259
Clear Channel Outdoor Holdings
CCO
$1.23B
| $32.7K | ﹤0.01% |
+14,800
| New | +$27.5K |
|
260
Ocean Power Technologies
OPTT
$49.9M
| $13.4K | ﹤0.01% |
44,800
+800
| +2% | +$360 |
|
261
Matinas BioPharma
MTNB
$1.81M
| $7.45K | ﹤0.01% |
12,720
-23,900
| -65% | -$28.2K |
|
|
262
PUT
Palantir
PLTR
$413B
| $1.96K | ﹤0.01% |
+14,000
| New | +$2.53M |
|
|
UTF.RT
263
DELISTED
Cohen & Steers Infrastructure Fund Rights exp Oct 16 2025
UTF.RT
| – | – |
-19,085
| Closed | -$1.49K |
|
Similar funds
OM
TVAMP
BCM
MWA
GWM
TI
JGUA
HCM
Sargent Investment Group's Q4 2025 Portfolio in Review
As of Q4 2025, Sargent Investment Group held 264 positions worth $797M, up 14% from $702M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Sargent Investment Group deployed $94.4M of net new capital in Q4 2025, opening 143 new positions and adding to 46 existing holdings. Its largest new stake was Akre Focus ETF: 92,801 shares worth $6.08M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 34% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Palantir, an estimated $10.1M trimmed.
- Sargent Investment Group's largest Q4 2025 buy was Akre Focus ETF: 92,801 shares worth $6.08M.
- Sargent Investment Group added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q4 2025, an estimated $9.69M increase.
- Sargent Investment Group's biggest Q4 2025 reduction was Palantir, cutting an estimated $10.1M.
- Sargent Investment Group fully exited Cohen & Steers Infrastructure Fund Rights exp Oct 16 2025 in Q4 2025, selling an estimated $1.49K.
- Sargent Investment Group's ten largest holdings make up 41% of its $797M portfolio in Q4 2025.
- Sargent Investment Group opened 143 new positions and closed 2 in Q4 2025.
- Sargent Investment Group's portfolio value rose 14% quarter-over-quarter to $797M.
Based on Sargent Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.